Related Experiment Video
Updated: May 4, 2026
07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
7.0K
HMGB3 characterization in gastric cancer
1Gastrointestinal Department of Southern Building, PLA General Hospital, Beijing, China.
Genetics and Molecular Research : GMR
|December 17, 2013
Summary
High-mobility group box 3 (HMGB3) protein interactions are key to understanding gastric cancer progression. This study identifies HMGB3-interacting transcription factors and conserved domains, offering insights into gastric cancer molecular mechanisms.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gastric cancer is a leading cause of cancer mortality globally.
- High-mobility group (HMG) chromosomal proteins are implicated in cancer progression.
- The specific role of HMGB3 in gastric cancer remains understudied.
Purpose of the Study:
- To investigate the co-expression network of HMGB3 with differentially expressed genes in gastric cancer.
- To identify transcription factors that regulate HMGB3 and its target genes.
- To understand the conserved functional domains of HMGB3 in the context of gastric cancer.
Main Methods:
- Analysis of the GSE17187 database for gene co-expression networks.
- Identification of differentially expressed genes and their relationship with HMGB3.
- Bioinformatic analysis to predict transcription factor interactions and conserved domains.
Main Results:
- A co-expression network revealed 31 relationships involving 11 differentially expressed genes, including known cancer-related genes like TBX5 and TFR2.
- Nine transcription factors (GATA3, MZF1, GATA1, GATA2, SRY, REL, NFYB, NFYC, NFYA) were identified as potential regulators of HMGB3.
- The HMG-box domain of HMGB3 showed high conservation across species, suggesting conserved functional importance.
Conclusions:
- HMGB3 interacts with specific transcription factors to regulate gene expression in gastric cancer.
- These interactions influence critical cellular processes such as proliferation, migration, and invasion.
- Understanding HMGB3's molecular mechanisms provides potential targets for gastric cancer therapy.
More Related Videos
Related Concept Videos
01:26Gastritis II: Pathophysiology
52
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
52
01:23Gastritis III: Clinical Manifestations and Management
1.9K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.9K
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
1.0K
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
1.0K